Offering conducted by agent Aegis Capital at $11.50 per ordinary share
By Devika Patel
Knoxville, Tenn., May 25 - Rosetta Genomics Ltd. said Thursday it plans a $6.56 million registered direct offering of stock that will be conducted through Aegis Capital Corp.
The company will sell 570,755 ordinary shares at $11.50 apiece. The price per share is a 2.31% premium to the May 23 closing share price of $11.24.
Settlement is expected May 31.
Proceeds will be used for operations and other general corporate purposes.
Based in Rehovot, Israel, Rosetta Genomics develops and provides microRNA-based molecular diagnostics.
| Issuer: | Rosetta Genomics Ltd.
|
| Issue: | Ordinary shares
|
| Amount: | $6,563,683
|
| Shares: | 570,755
|
| Price: | $11.50
|
| Warrants: | No
|
| Agent: | Aegis Capital Corp.
|
| Pricing date: | May 24
|
| Settlement date: | May 31
|
| Stock symbol: | Nasdaq: ROSG
|
| Stock price: | $11.24 at close May 23
|
| Market cap: | $16.88 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
